Current Period Performance Forecast The company anticipates a significant year-on-year increase in its 2025 first-half net profit, with attributable net profit projected between 55 million and 70 million yuan Performance Forecast Summary | Item | Current Period | Prior Year Period | | :--- | :--- | :--- | | Net Profit Attributable to Shareholders | Profit: 55.00 Million Yuan—70.00 Million Yuan | Profit: 29.4788 Million Yuan | | Growth Rate | Year-on-year increase: 86.57% —137.46% | - | | Net Profit After Deducting Non-recurring Gains and Losses | Profit: 42.00 Million Yuan—57.00 Million Yuan | Profit: 20.4493 Million Yuan | | Growth Rate | Year-on-year increase: 105.39% —178.74% | - | | Basic Earnings Per Share | Profit: 0.1466 Yuan/share—0.1866 Yuan/share | Profit: 0.0750 Yuan/share | - The company characterizes the current period's performance forecast as "year-on-year growth"3 Communication with Accounting Firm The financial data presented in this performance forecast represents preliminary internal estimates, pending pre-audit by an independent accounting firm - The financial data in this performance forecast is a preliminary estimate by the company's finance department and has not been pre-audited by an accounting firm3 Explanation of Performance Changes Current period performance growth is primarily attributed to stable button mushroom prices, increased joint venture investment income, higher wealth management gains, and reduced financial expenses - Key drivers of performance growth include: - Stable to rising sales prices for button mushrooms, enhancing single-product operating performance - Increased investment income from the joint venture Tianshui Jinxing Biotechnology Co., Ltd. year-on-year - Approximately 8 million yuan increase in investment income and fair value changes from wealth management products year-on-year - A year-on-year decrease in financial expenses4 Risk Warning and Other Related Disclosures The company cautions investors that this preliminary, unaudited performance forecast is subject to change, with final figures to be confirmed in the 2025 semi-annual report - The company emphasizes that this performance forecast is a preliminary estimate by the finance department, unaudited, with final data subject to the 2025 semi-annual report, and advises investors to be aware of investment risks56
众兴菌业(002772) - 2025 Q2 - 季度业绩预告